Phase I Trial of Ex Vivo Expanded Donor Gamma Delta T Cell Immunotherapy to Prevent Acute Myeloid Leukemia Relapse after Allogeneic TransplantationNelli Bejanyan, Marco L. Davila, Jongphil Kim et al.|Blood|2024Cited by 2